|
Efficacy of humanized CD19-targeted chimeric antigen receptor (CAR)-modified T cells in children with relapsed ALL. |
|
|
Consulting or Advisory Role - Novartis |
Research Funding - Novartis |
|
|
Travel, Accommodations, Expenses - Therakos |
|
|
Employment - Endo Pharmaceuticals (I) |
Stock and Other Ownership Interests - Endo Pharmaceuticals (I) |
|
|
|
Travel, Accommodations, Expenses - Sigma-Tau |
|
|
Consulting or Advisory Role - Janssen |
Research Funding - Novartis (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Research Funding - Novartis (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Patents, Royalties, Other Intellectual Property - Novartis |
|
|
Stock and Other Ownership Interests - Tmunity Therapeutics, Inc. |
|
Consulting or Advisory Role - TERUMO |
Research Funding - Novartis; Takara Bio |
Patents, Royalties, Other Intellectual Property - intellectual property and patents in the field of cell and gene therapy |
Travel, Accommodations, Expenses - TERUMO |
|
|
Employment - Genentech/Roche (I) |
Stock and Other Ownership Interests - Genentech/Roche (I) |
|
Consulting or Advisory Role - Novartis |
Research Funding - Novartis |
Patents, Royalties, Other Intellectual Property - Patent/royalty rights |
Travel, Accommodations, Expenses - Immunovative Therapies |
|
|
Research Funding - Novartis |
|
|
Research Funding - Novartis (Inst) |
Patents, Royalties, Other Intellectual Property - Patents |
|
|
Stock and Other Ownership Interests - Celldex; Immune Design; Tmunity Therapeutics, Inc. |
Honoraria - Johnson & Johnson; Novartis; Pfizer |
Consulting or Advisory Role - Celldex; Immune Design |
Research Funding - Novartis |
Patents, Royalties, Other Intellectual Property - IP licensed to Novartis; Royalties paid to University of Pennsylvania; IP licensed to Tmunity (Inst); Office of Naval Research; IP and patent royalties |
|
|
Consulting or Advisory Role - Janssen; Janssen; Jazz Pharmaceuticals; Novartis; Pfizer |
Research Funding - Novartis |